Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5000459
[patent_doc_number] => 20070043093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same'
[patent_app_type] => utility
[patent_app_number] => 10/582580
[patent_app_country] => US
[patent_app_date] => 2003-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9372
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20070043093.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582580 | Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same | Dec 24, 2003 | Issued |
Array
(
[id] => 5237214
[patent_doc_number] => 20070129371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Novel ethylenediamine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/539995
[patent_app_country] => US
[patent_app_date] => 2003-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113481
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129371.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539995
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539995 | Novel ethylenediamine derivatives | Dec 23, 2003 | Abandoned |
Array
(
[id] => 4765711
[patent_doc_number] => 20080176923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Proline Derivatives Used as Pharmaceutical Active Ingredients for the Treatment of Tumors'
[patent_app_type] => utility
[patent_app_number] => 10/596636
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11485
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176923.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596636 | Proline Derivatives Used as Pharmaceutical Active Ingredients for the Treatment of Tumors | Dec 17, 2003 | Abandoned |
Array
(
[id] => 5815033
[patent_doc_number] => 20060084682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Thrombopoietin mimetics'
[patent_app_type] => utility
[patent_app_number] => 10/538252
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10276
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538252 | Thrombopoietin mimetics | Dec 11, 2003 | Abandoned |
Array
(
[id] => 5035444
[patent_doc_number] => 20070099983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Aminocyclohexyl ether compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/555364
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 165
[patent_figures_cnt] => 165
[patent_no_of_words] => 73726
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555364 | Aminocyclohexyl ether compounds and uses thereof | Oct 30, 2003 | Abandoned |
Array
(
[id] => 5895530
[patent_doc_number] => 20060004069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Agent for preventing or treating neuropathy'
[patent_app_type] => utility
[patent_app_number] => 10/532667
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68080
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20060004069.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532667 | Agent for preventing or treating neuropathy | Oct 29, 2003 | Issued |
Array
(
[id] => 5711030
[patent_doc_number] => 20060052375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Bis-alkylbenzylamines'
[patent_app_type] => utility
[patent_app_number] => 10/531232
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3860
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531232
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531232 | Bis-alkylbenzylamines | Oct 13, 2003 | Abandoned |
Array
(
[id] => 5748475
[patent_doc_number] => 20060111407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity'
[patent_app_type] => utility
[patent_app_number] => 10/530945
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3113
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530945 | Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity | Oct 9, 2003 | Abandoned |
Array
(
[id] => 5859927
[patent_doc_number] => 20060229324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Quinazolin-4-one derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/529946
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25324
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529946 | Quinazolin-4-one derivatives | Oct 1, 2003 | Abandoned |
Array
(
[id] => 5866300
[patent_doc_number] => 20060100431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Biologically active compounds'
[patent_app_type] => utility
[patent_app_number] => 10/521354
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 165596
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100431.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521354 | Biologically active compounds | Jul 14, 2003 | Abandoned |
Array
(
[id] => 64452
[patent_doc_number] => 07759501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Process for producing N-monoalkyl-3-hydroxy-3-(2-thienyl) propanamine and intermediate'
[patent_app_type] => utility
[patent_app_number] => 10/523287
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3551
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759501.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523287
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523287 | Process for producing N-monoalkyl-3-hydroxy-3-(2-thienyl) propanamine and intermediate | Jul 14, 2003 | Issued |
Array
(
[id] => 4995172
[patent_doc_number] => 20070010517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Pharmaceutical salts of reboxetine'
[patent_app_type] => utility
[patent_app_number] => 10/588808
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3570
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588808 | Pharmaceutical salts of reboxetine | Jun 3, 2003 | Abandoned |
Array
(
[id] => 7198228
[patent_doc_number] => 20050164674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Mobile telephone fare forehead payment registration system and device'
[patent_app_type] => utility
[patent_app_number] => 10/514343
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5627
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164674.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514343
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514343 | Mobile telephone fare forehead payment registration system and device | May 12, 2003 | Abandoned |
Array
(
[id] => 5743675
[patent_doc_number] => 20060089400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolylcis/trans-isomerases'
[patent_app_type] => utility
[patent_app_number] => 10/514279
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8814
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089400.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514279 | Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolylcis/trans-isomerases | May 1, 2003 | Abandoned |
Array
(
[id] => 7225306
[patent_doc_number] => 20050261335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Carvedilol formulations'
[patent_app_type] => utility
[patent_app_number] => 10/513235
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3625
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261335.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513235 | Carvedilol formulations | May 1, 2003 | Abandoned |
Array
(
[id] => 5808416
[patent_doc_number] => 20060094771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Carvedilol pharmasolve solvate'
[patent_app_type] => utility
[patent_app_number] => 10/513234
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1066
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513234 | Carvedilol pharmasolve solvate | May 1, 2003 | Abandoned |
Array
(
[id] => 7075511
[patent_doc_number] => 20050148779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Carvedilol monocitrate monohydrate'
[patent_app_type] => utility
[patent_app_number] => 10/512628
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2538
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512628 | Carvedilol monocitrate monohydrate | Apr 29, 2003 | Abandoned |
Array
(
[id] => 6911796
[patent_doc_number] => 20050175554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Aminophenylbenzothiazole compounds'
[patent_app_type] => utility
[patent_app_number] => 10/511852
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13262
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511852 | Aminophenylbenzothiazole compounds | Apr 13, 2003 | Abandoned |
Array
(
[id] => 82337
[patent_doc_number] => 07745639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Mitotic kinesin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/506702
[patent_app_country] => US
[patent_app_date] => 2003-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26495
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506702
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506702 | Mitotic kinesin inhibitors | Mar 3, 2003 | Issued |
Array
(
[id] => 4567360
[patent_doc_number] => 07829044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => 'Phosphonamides, process for producing the same, and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/506424
[patent_app_country] => US
[patent_app_date] => 2003-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11605
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506424 | Phosphonamides, process for producing the same, and use thereof | Mar 2, 2003 | Issued |